HB 382 Maryland House of Delegates · 2023 Regular Session

Maryland Department of Health and Prescription Drug Affordability Board - Managed Care Organizations and Prescription Drug Claims - Study

Bill status signed all 5 stages cleared

Introduction

Jan 2023

Committee Review

Apr 2023

House of Delegates Passage

Apr 2023

Senate Passage

Apr 2023

Signed into Law

Apr 2023

Introduced Jan 26, 2023 Signed Apr 24, 2023

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

14

Key actions

8

Committee

6

Apr 24, 2023

Signed into law

Approved by the Governor - Chapter 217

executive

Apr 5, 2023

Lower · Passed

Returned Passed

lower

Apr 5, 2023

Upper · Passed

Third Reading Passed

upper

Apr 3, 2023

Upper · Passed

Favorable Adopted

upper

Apr 3, 2023

Upper · Passed

Favorable Report by Finance

upper

Mar 16, 2023

Committee

Referred Finance

upper

Mar 15, 2023

Lower · Passed

Third Reading Passed

lower

Mar 14, 2023

Lower · Passed

Favorable with Amendments {

lower

Mar 13, 2023

Lower · Passed

Favorable with Amendments Report by Health and Government Operations

lower

Jan 26, 2023

Committee

First Reading Health and Government Operations

lower

20 primary · 0 co-sponsors

Sponsors